Jefferies

Jefferies PCA’s Secondary Advisory Team continues to build momentum in early 2026, advising on $20 billion of transaction volume year to date across 25 closed and signed deals. Since January 2022, the team has advised on approximately $120 billion across more than 240 transactions, delivering high impact solutions to clients through an integrated, high touch approach to the global secondaries market.

Jefferies is pleased to have served as Exclusive Financial Advisor to Intermedia on its sale to 26North. This transaction builds upon Jefferies' strong track record in the segment, advising on most of the industry's landmark transactions. Jefferies continues to dominate as the leader in providing advisory expertise in the AI-driven communications, contact center and CX ecosystem.

Congratulations to Fremman Capital on the final closing of its second fund, Fremman II MM, which secured total commitments of €808 million, above the €750 million target size. Commitments were raised from a diverse group of institutional investors across Europe, the Americas, Asia and the Middle East. Jefferies is proud to have served as exclusive global placement agent for the Fremman II capital raise.

Jefferies congratulates Centessa (NASDAQ:CNTA) on the Company’s Sale to Eli Lilly (NYSE:LLY) for $6.3 billion in upfront cash consideration and a CVR representing an additional potential $1.5 billion. We were honored to serve as Joint Financial Advisor on this landmark transaction. Centessa is a clinical-stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are transformational for patients. This transaction represents the second largest pre-filing CNS acquisition of all time based on upfront equity value, per BioMedTracker. The deal reinforces our position as a trusted, long-term partner of choice in the biopharmaceutical space on mission critical, transformative strategic and capital formation transactions, as well as our strong client coverage and cross-border execution capabilities.

Last week, Jefferies was proud to host our 6th annual Pan European Mid Cap Conference at The Rosewood, London, welcoming close to 500 institutional investors and management teams from over 200 corporates for nearly 1,500 one to one meetings. The conference was further elevated by insightful keynote addresses from Sir Robin Niblett, Distinguished Fellow at Chatham House, who shared his views on the evolving geopolitical landscape, and Megan Greene, External Member of the Bank of England’s MPC, who offered a forward-looking perspective on the UK outlook as we move through 2026 and beyond. We would like to thank everyone who participated and helped make the event such a standout success. We look forward to welcoming you again in 2027!

We are honored to receive GlobalCapital’s European award for CLO (Collateralized Loan Obligation) “Bank of the Year” for the fifth consecutive year. Jefferies has solidified its position as a leading force in Europe’s primary CLO market, earning recognition for excellence in the asset class from more than 3,000 market participants who voted. This achievement reflects our deep relationships across the buy and sell side and our proven ability to navigate a rapidly evolving market environment. Congratulations to the entire team on a well‑deserved win.

Jefferies congratulates Forgent Power Solutions, Inc. and Neos Partners on the company’s $885 million follow-on common stock offering. We are proud to have served as joint lead book-running manager for the offering. This transaction builds on Forgent’s successful IPO, led by Jefferies earlier this year, and underscores our proven ability to deliver exceptional outcomes for clients—even in challenging markets.

It was such a pleasure to host our clients and industry partners for a morning of insightful and thoughtful dialogue around Fixed Income Market structure and showcasing Jefferies Thought Leadership. The quality of engagement in the room was a real highlight. We look forward to building on these conversations with our clients in the months ahead.

Jefferies is pleased to have served as Joint Global Coordinator and Joint Bookrunner for the landmark IPO of Sunway Healthcare Group, one of the leading providers of integrated healthcare in Malaysia. This is the largest IPO in Malaysia, and in Healthcare Services across ASEAN in almost a decade. Jefferies is honoured to be part of another market defining transaction in the healthcare sector in Asia, delivering deep insights and leveraging the connectivity of the Jefferies global franchise across investment banking and equities.